[admin]

Understanding the Core Question: Portable or Benchtop for PSA Testing

Clinicians evaluating fluorescence immunoassay (FIA) options for prostate specific antigen (PSA) assessment are increasingly asking a practical question: does a portable PSA analyzer outperform a traditional benchtop FIA system when it comes to real-world point-of-care use? VivaChek Biotech (Hangzhou) Co., Ltd., operating under the VivaDiag diagnostic brand, has built its product portfolio specifically around answering this question, offering both a current handheld analyzer and earlier, larger-format models that illustrate the tradeoffs between portability and fixed laboratory infrastructure.

Why Point-of-Care PSA Testing Matters

Prostate cancer is the second most common cancer in men globally, with about 1.47 million new cases and about 400,000 deaths worldwide in 2022. Early prostate cancer often presents with few or no symptoms, which means accessible screening and assessment tools are essential rather than optional. Aging populations are increasing the overall disease burden, driving demand for earlier detection pathways that do not depend entirely on central laboratory scheduling.

Traditional fluorescence immunoassay testing has historically been constrained by laboratory-bound instruments, larger sample volume requirements, long turnaround times, and high operational costs. Central laboratory testing typically involves venipuncture, larger sample volumes, and longer turnaround, creating barriers to timely point-of-care assessment. This is the exact gap that VivaChek’s portable FIA platform is designed to close.

The Portable Option: VivaDiag Portable FIA Analyzer VIM300H

VivaChek’s current-generation portable analyzer, the VivaDiag Portable FIA Analyzer VIM300H, is a compact, point-of-care immunofluorescence analyzer built on a photoelectric detection based immunofluorescence detection device. It measures 146 x 77.6 x 55.5 mm, weighs just 370 g, and runs on a removable and rechargeable lithium battery for up to 10 hours of continuous operation. Its 3.97-inch color touch screen supports intuitive operation, while USB, Wi-Fi, and optional Bluetooth connectivity allow data transfer without being tethered to a fixed network. The analyzer stores 10,000 results in memory and supports 39 venous-blood parameters along with more than 20 capillary-blood-ready parameters, giving clinical teams a broad test menu in a handheld form factor.

Paired with this analyzer is the VivaDiag Prostate Specific Antigen (PSA) Test Kit (FIA), which quantitatively determines PSA in human whole blood (via fingerstick or venipuncture), serum, or plasma, delivering results in 15 minutes. The kit requires only 20 μL of sample, reducing the barrier to testing compared with venipuncture-only workflows. Its measuring range spans 0.1–100 ng/mL for serum/plasma and 0.37–100 ng/mL for whole blood — notably broader at the low end than competitor whole blood ranges of 2–100 ng/mL, which allows detection at lower PSA concentrations. The kit’s added mixed solution volume of 75 μL matches the lowest among compared competitors, and intermediate precision CV values of 4.97% (low concentration), 4.05% (medium concentration), and 4.69% (high concentration) demonstrate consistent quantitative performance within an 18–25°C operating temperature range.

The Benchtop Comparison: Larger-Format FIA Instruments

By contrast, benchtop-style FIA instruments — represented in VivaChek’s own product history by the prior-generation VIM3000 — are built for fixed-location use. The VIM3000 weighs 1.8 kg, measures 192 x 209 x 169 mm, and features a 7-inch color touch screen along with a built-in thermal printer, eliminating the need for an external printing accessory. It also includes an Ethernet port (RJ-45) alongside USB and Wi-Fi connectivity, supporting wired laboratory information system integration — a capability suited to laboratory and fixed-location settings rather than mobile deployment.

This comparison highlights the core tradeoff: benchtop-class systems like the VIM3000 offer a larger display and built-in printing convenient for a stationary lab bench, while the portable VIM300H prioritizes mobility, battery independence, and a lighter footprint suited to decentralized care.

Design and Deployment: Where Portability Changes the Workflow

The practical difference between portable and benchtop FIA systems becomes clearest in deployment scenarios. A benchtop unit is well suited to a laboratory space with consistent power and network access. A portable analyzer such as the VIM300H, however, is designed for environments where space and mobility are constrained — including general practice and primary care clinics, community health centers, township and rural clinics, ambulances and paramedic units, mobile medical units, emergency department triage, urgent care centers, corporate and school health clinics, retail pharmacy testing services, home healthcare and domiciliary visits, research and field operations, and remote offshore and maritime stations. The 10-hour battery life and 370 g weight make continuous operation across clinical shifts and mobile workflows possible without frequent recharging or bulky equipment transport.

Regulatory Compliance Supporting Professional Use

Both the analyzer and test kit are positioned for professional clinical use under applicable European in vitro diagnostic requirements. The system holds an EU Quality Management System Certificate under Regulation (EU) 2017/746 on In Vitro Diagnostic Devices (Annex IX Chapter I and III) and carries CE Marking with Notified Body Identification Number 0344, issued by DEKRA. The PSA Test Kit is IVDR-certified for professional use, supporting market access across VivaChek’s priority European markets of Germany, France, Italy, Spain, and the UK. These credentials are intended for clinical laboratory professionals as an aid in the management and monitoring of prostate cancer or other prostate disorders, and the system is not intended for self-testing or near-patient testing by non-professionals.

Making the Choice: Matching the System to the Setting

For organizations weighing a portable PSA analyzer against a benchtop FIA system, the decision ultimately depends on where testing needs to happen. Fixed laboratory environments with stable infrastructure may continue to value the larger screen and built-in printer of a benchtop-style unit such as the VIM3000. For nearly every other setting — primary care, emergency and pre-hospital care, niche community and retail testing, and field operations — the VivaDiag Portable FIA Analyzer VIM300H, paired with the VivaDiag PSA Test Kit, offers a 15-minute, 20 μL, IVDR-certified quantitative solution that extends laboratory-quality PSA assessment to the point of care. As VivaChek prepares its VIM300H for broader distribution — with sample units readied ahead of Mid-Autumn Festival, roughly 78 finished units expected by late October, and trial production concluding in December — the portable format is positioned to expand access to timely prostate health assessment well beyond the traditional central laboratory bench.

https://www.vivachek.com
VivaChek Biotech (Hangzhou) Co., Ltd.

[Author]

Posts